Odyssey Health Income Statement

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Selling, General & Admin	0.94	1.02	2.08	2.12	2.92	4.79
Research & Development	-	-	0.06	0.2	1.32	1.63
Operating Expenses	0.94	1.02	2.14	5.14	8.11	6.42
Operating Income	-0.94	-1.02	-2.14	-5.14	-8.11	-6.42
Interest Expense	-1.09	-0.25	-0.52	-0.61	-0.84	-1.07
Other Non Operating Income (Expenses)	-1.6	-0.01	0.01	0.01	0.5	-
EBT Excluding Unusual Items	-3.63	-1.28	-2.65	-5.75	-8.44	-7.49
Gain (Loss) on Sale of Investments	-0.03	-0.46	-14.59	-	-	-
Gain (Loss) on Sale of Assets	-	-	16.4	-	-	-
Other Unusual Items	0.09	-	-	-	-	0.05
Pretax Income	-3.57	-1.74	-0.84	-5.92	-8.44	-16.88
Net Income	-3.57	-1.74	-0.84	-5.92	-8.44	-16.88
Preferred Dividends & Other Adjustments	-	-	0.06	-	-	-
Net Income to Common	-3.57	-1.74	-0.91	-5.92	-8.44	-16.88
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	107	105	97	83	89	94
Shares Outstanding (Diluted)	107	105	97	83	89	94
Shares Change	1.84%	7.88%	17.40%	-7.10%	-5.06%	7.59%
EPS (Basic)	-0.03	-0.02	-0.01	-0.07	-0.09	-0.18
EPS (Diluted)	-0.04	-0.02	-0.01	-0.07	-0.09	-0.18
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Free Cash Flow	-0.93	-0.35	-1.22	-1.47	-3.18	-3.42
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.02	-0.04	-0.04
EBITDA	-	-1.02	-2.14	-5.14	-8.1	-6.42
D&A For EBITDA	-	0	0	0	0	0.01
EBIT	-0.94	-1.02	-2.14	-5.14	-8.11	-6.42